Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Paul Pollack, MD
Abbott
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
189 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Ref # / Investigator 3077
Graz, Austria
- Site Ref # / Investigator 2975
Vienna, Austria
- Site Ref # / Investigator 2976
Vienna, Austria
- Site Ref # / Investigator 2978
Vienna, Austria
- Site Ref # / Investigator 2977
Wels, Austria
- Site Ref # / Investigator 3023
Bonheiden, Belgium
- Site Ref # / Investigator 3021
Brussels, Belgium
- Site Ref # / Investigator 3074
Brussels, Belgium
- Site Ref # / Investigator 3020
Edegem, Belgium
- Site Ref # / Investigator 3625
Ghent, Belgium
- Site Ref # / Investigator 3773
Leuven, Belgium
- Site Ref # / Investigator 3022
Liège, Belgium
- Site Ref # / Investigator 3047
Roeselare, Belgium
- Site Ref # / Investigator 3893
Brno, Czechia
- Site Ref # / Investigator 4657
Olomouc, Czechia
- Site Ref # / Investigator 4659
Prague, Czechia
- Site Ref # / Investigator 4660
Prague, Czechia
- Site Ref # / Investigator 3075
Aalborg, Denmark
- Site Ref # / Investigator 3037
Aarhus C, Denmark
- Site Ref # / Investigator 3088
Elsinore, Denmark
- Site Ref # / Investigator 3076
Hvidovre, Denmark
- Site Ref # / Investigator 3019
Odense C, Denmark
- Site Ref # / Investigator 3623
Hyvinkää, Finland
- Site Ref # / Investigator 3032
Amiens, France
- Site Ref # / Investigator 3012
Besançon, France
- Site Ref # / Investigator 2993
Bordeaux, France
- Site Ref # / Investigator 2983
Béthune, France
- Site Ref # / Investigator 2982
Caen, France
- Site Ref # / Investigator 3015
Clichy, France
- Site Ref # / Investigator 3011
Colombes, France
- Site Ref # / Investigator 3030
Créteil, France
- Site Ref # / Investigator 3033
Créteil, France
- Site Ref # / Investigator 3048
Grenoble, France
- Site Ref # / Investigator 3097
Lille, France
- Site Ref # / Investigator 3031
Marseille, France
- Site Ref # / Investigator 2985
Montfermeil, France
- Site Ref # / Investigator 2994
Montpellier, France
- Site Ref # / Investigator 3014
Nantes, France
- Site Ref # / Investigator 3029
Nice, France
- Site Ref # / Investigator 2995
Paris, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2006
- Primary completion
- 31 Jul 2008
- Completion
- 31 Jul 2008
- Last update posted
- 10 Oct 2011
- Registered enrollment
- 945
- Registry id
- NCT00409617
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.